0 items in cart   Total:$0
 Home 
 Recommend 
 New Arrival 
 Special Offer 
 Brands 
 Gifts 
 About Us 
 Contact Us 
 Choose default layout:       Call Us:+1268 562-2888 +1268 562-6662
     Advanced Search    Keys:
Your present position: xpzsupermarket -> Member News
Sign In
Username:
Password:use soft keyboard
 Free Register!
 Forgot your password?
Top Sales
Natura Oval Citrine Gemst
$1,200
Item Specifics
$557
Hotpoint TVM562 Graphite
$118
Item Specifics - Wristwat
$7,736
LG 37LG5000 37in 1080P Di
$510
Barkley's unique jail time
Close Admin:tanyunfei Time:2009-3-10 Views: 91
Schering-Plough will add strength in the prized area of biologic drugs, which are made from living cells. It will also give Merck one of the world's biggest animal health businesses and a sizable consumer health division that includes products such as allergy pill Claritin, Dr. Scholl's foot products and the Coppertone sun-care line. Merck Chairman and CEO Richard Clark told The Associated Press the company will be "well-positioned for sustainable growth through scientific innovation." Big drugmakers are facing slumping sales as the blockbuster drugs of the 1990s lose patent protection, complicated by a dearth of new drugs. Schering-Plough, however, has patent protection for key products until the middle of the next decade and what is considered one of the best product pipelines. Still, analyst Steve Brozak of WBB Securities said the deal is mainly about Merck "buying revenue and buying earnings." "It's a good short-term fix, but it unfortunately makes it more complicated for the long term," Brozak said.



YAHOO!  -  Google  -  Netease  -  MSN  -  EBAY  -  Amazon  -  
Tel:+1268 562-2888 +1268 562-6662 Email:etongehong@163.com
Address:Factory Road Saint John's Antigua and Barbuda Code:
Copyright © XPZ International Trading Ltd.  
Pages execution time:3,136.719 ms  Powered By:ZhiBian.Net